FHI will not promise vaccines to all adults in the first half of 2021 – NRK Norway – Summary of news from different parts of the country



[ad_1]

This article is over a month old and may contain outdated advice from authorities on coronary heart disease.

Stay up to date on the NRK overview or on the FHI website.

Sweden’s Minister of Social Affairs Lena Hallengren told a news conference Tuesday night that all people over the age of 18, and the youngest in risk groups, will receive the coronary vaccine during the first half of 2021.

Sweden, like Norway, must have guaranteed vaccines for the entire population for the entire population.

– There are bright spots, there is a spring, said Hallengren.

He stressed that vaccination should be able to start already by the turn of the year. It was previously estimated that this could happen during the first quarter.

Press conference korona Sweden

Swedish Minister for Social Affairs Lena Hallengren (S) and Prime Minister Stefan Löfven (S) at Tuesday’s press conference on the status of the crown in Sweden.

Photo: Henrik Montgomery / tt / NTB

– If they can do it, we can do it.

Preben Aavitsland, chief physician at the National Institute of Public Health, tells NRK the following about the promises of the Swedish Minister of Social Affairs.

– It is ambitious, but we have the same purchasing agreement as Sweden and we will receive the same number of vaccines per inhabitant, says Aavitsland, before he gets a bit based on the issue.

– So if they have that goal, that is, if they can do it, we can do it too. But so far we do not dare to promise it in the first half of the year, says the superior of the FFHI.

When asked directly when he thinks the adult part of the Norwegian population will be vaccinated, he replies that “hopefully it will be during 2021.”



NRK
Explain

When and how do we Norwegians get vaccinated against the crown?

for answers

Vaccination begins in early January, as soon as the first vaccines arrive in Norway. This assumes that the vaccine is approved for use by the EU. It probably happens around New Years.

How is the vaccination done?

Those who are offered a vaccine will be contacted.

You get one dose first, then another dose after a few weeks.

The vaccine is voluntary. It’s free.

Who gets vaccinated first?

Seniors get first, those living in nursing homes take priority. I saw those over 64, as well as younger people who have underlying diseases. Then the health professionals.

Before Easter, probably 70% of the people in the risk group have been vaccinated.

How do I know if I am being prioritized and receiving the vaccine?

Your GP or municipality will contact you.

If you are not in the risk group, you will probably be offered a vaccination between Easter and summer.

There are different vaccines. Can I choose which one I want?

Health authorities decide on the basis of which vaccines are available and which ones are the most suitable for different groups.

If I am not offered the vaccine, can I get it if I pay for it myself?

No, it is not possible to buy in advance in the queue.

What about the side effects?

Authorities have promised to be open about any side effects when they receive information about it. So far, during testing, no serious side effects have been reported in the vaccines that are most relevant to Norway.

This is how the vaccine works:

Crucial access

Aavitsland says it is access to the vaccine that will be decisive for how quickly the adult part of the Norwegian population can be vaccinated. Trust the logistics.

FHI Consultant Preben Aavitsland

FHI chief physician Preben Aavitsland comments on the news from Sweden from his headquarters.

Photo: NRK / NRK

It points out that 1.2 million Norwegians were vaccinated against the common flu by the health service in a few weeks this fall.

– It is probably not the capacity in the health service that should be on. It’s simply how many vaccines we get and how quickly we get them.

Solberg: high level of ambition

Prime Minister Erna Solberg (H) tells NTB that the government wants to vaccinate as many people as possible, but that the Swedes and Danes “advertise” more in the field of vaccines.

– We get as many vaccinations as they get in relation to the size of our population, but we’ve been a little less advertising and perhaps a little more concerned with making sure we have solid fish, says Solberg.

Solberg says that Norway’s level of ambition is as high as that of Sweden and Denmark, and that all adults should get vaccinated as soon as possible. But she doesn’t promise anything.

– It depends on the production of the vaccine not being stopped and there are no side effects. So there are a lot of questions, but our level of ambition is exactly the same, says Solberg.

AstraZeneca, University of Oxford

The corona vaccine developed at the University of Oxford prevents the symptoms of COVID-19 in 70 percent of cases.

The AZD1222 vaccine is based on the monkey ChAdOx1 virus. This virus is modified so that it cannot make copies of itself, so it does not cause disease. The researchers also changed the virus to carry additional information. The additional information causes your body to produce the so-called “spike protein” of the coronavirus.

What happens is the following: You get the vaccine in your body. The vaccine virus enters your cells. Inside cells, the production system discovers the additional information. Many copies of the “spike protein” are made. These copies are secreted by cells. Your immune system detects these proteins. An immune response is triggered. Antibodies against the coronavirus are produced and the immune system remembers that it is something to react to.

You have been vaccinated.

Biontech, Fosun Pharma and Pfizer

The German pharmaceutical company BioNTech reports that its coronary vaccine has been shown to be 95 percent effective. The UK will start vaccinating in December.

The BNT162b2 vaccine relies on your body’s system for building things. The vaccine is just building instructions for the cells. The instructions are based on the same codes that cells use all the time for this purpose. These are called mRNAs or “messenger ribonucleic acids.”

What happens is the following:

The vaccine is injected into your body. The information from the vaccine reaches the machines in the cells that make proteins. These machines build copies of the so-called “spike protein” of the coronavirus. These proteins are secreted by cells and detected by the immune system. The immune system reacts in the same way as if the real coronavirus had entered the body. Antibodies are produced and the immune system remembers that the coronavirus is something foreign to react to.

You have been vaccinated.

Johnson and Johnson

The vaccine is in phase 3 of development.

Ad26 vaccine. COV2.S is based on the ad26 virus. It is a cold virus that circulates among humans. This is the virus that has been modified by researchers so that it cannot cause disease in humans. It also carries an extra gene, a bit of extra information. The extra information causes your body to produce the so-called “spike protein” of the coronavirus.

What happens is the following:

You get the vaccine in your body. The vaccine virus enters your cells. Inside cells, the production system discovers the additional information. Many copies of the “spike protein” are made. These copies are secreted by cells. Your immune system detects these proteins. An immune response is triggered. Antibodies against the coronavirus are produced and the immune system remembers that it is something to react to.

You have been vaccinated.

Novavax with partners

Novavax expects results in early 2021.

The NVX-CoV2373 vaccine is based on what are called nanoparticles. These are microscopic structures. The Novavax vaccine has nanoparticles that are primarily an extract from the Quillaja saponaria plant. This extract is used in much of the world as a food additive, but it also has medicinal properties. In addition, the vaccine particles are made up of cholesterol and fatty acids. The particles also carry the “spike protein” of the coronavirus. These nails are produced in genetically modified yeast cells and are added to the particles in the production process.

What happens is the following:

The vaccine works in two ways. Nanoparticles make your immune system respond better, and spike proteins make your immune system react as if a real coronavirus has entered the body.

You have been vaccinated.

Modern

US Secretary of Health Alax Azar says that the coronary vaccine at Pfizer and Moderna can be approved and distributed in a few weeks.

The mRNA-1273 vaccine relies on your body’s system to build things. The vaccine is just building instructions for the cells. The instructions are based on the same codes that cells use all the time for this purpose. These are called mRNAs or “messenger ribonucleic acids.”

What happens is the following:

The vaccine is injected into your body. The information from the vaccine reaches the machines in the cells that make proteins. These machines build copies of the so-called “spike protein” of the coronavirus. These proteins are secreted by cells and detected by the immune system. The immune system reacts in the same way as if the real coronavirus had entered the body. Antibodies are produced and the immune system remembers that the coronavirus is something foreign to react to.

You have been vaccinated.

In this phase, the vaccine is given to a small group of young, healthy people to see if the immune system responds. Researchers are also investigating whether it causes powerful and perhaps dangerous side effects. Also, based on the results, it is estimated how much vaccine should be administered.

In this phase, the vaccine is administered to a larger and wider group. The aim is to find variations in the response of the immune system and more data on side effects and the most reasonable amount of vaccine.

In this phase, it is investigated if the vaccine provides protection against the disease and if it causes more rare side effects. Several thousand people receive the vaccine and several thousand people receive a sham vaccine. Nobody knows who gets what. This is to ensure good scientific data.

The vaccine is ready for distribution.

The vaccine is approved for use in the EU and Norway.

Nine billion Swedish crowns

Mass vaccination is a major logistical challenge, and Swedish municipalities and regions are gearing up with full force to be ready when an approved vaccine becomes available.

Older people, people in risk groups and employees in the health and care sector are first in line.

Vaccination must be free in Sweden. The state bears the entire bill for the vaccination program of around SEK 9 billion. Regional authorities are responsible for carrying out vaccination.

The UK began vaccination on Tuesday, after urgently approving Pfizer’s vaccine for national use. The country has initially obtained access to 800,000 doses.

Sweden and Norway will apparently wait until a vaccine is approved in the EU, which can happen on Christmas Eve.

[ad_2]